Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effects of Selective Laser Trabeculoplasty (SLT)

This study has been terminated.
(PI left the University)
Sponsor:
Information provided by (Responsible Party):
University of Kentucky
ClinicalTrials.gov Identifier:
NCT00986141
First received: September 25, 2009
Last updated: April 23, 2013
Last verified: April 2013
  Purpose

Primary objective is to evaluate the effect of selective laser trabeculoplasty (SLT) on the diurnal intraocular pressure variation in open-angle glaucoma patients (OAG).


Condition Intervention Phase
Glaucoma
Procedure: Surgery
Procedure: Selective Laser Trabeculoplasty
Phase 4

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Effect of Selective Laser Trabeculoplasty (SLT) on Diurnal Intraocular Pressure in Open-Angle Glaucoma Patients on Medical Treatment

Resource links provided by NLM:


Further study details as provided by University of Kentucky:

Primary Outcome Measures:
  • To evaluate the effect of selective laser trabeculoplasty on the diurnal intraocular pressure variation in OAG patients. [ Time Frame: Three years ] [ Designated as safety issue: No ]

Enrollment: 30
Study Start Date: May 2009
Study Completion Date: December 2012
Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
laser trabeculoplasty
Subjects with POAG and on medical treatment who are undergoing SLT
Procedure: Surgery
Selective Laser Trabeculoplasty for glaucoma
Other Name: Selective Laser Trabeculoplasty
Procedure: Selective Laser Trabeculoplasty
Glaucoma Treatment
Other Name: SLT
Surgery
Glaucoma laser treatment

Detailed Description:

This is a prospective observational study of OAG patients undergoing selective laser trabeculoplasty at the University of Kentucky Chandler Medical Center. The patients will be recruited over 12 months. Study will include 3 visits: pre-laser visit, visit for laser treatment and post-laser visit. All visits will occur within a 3-month period.

  Eligibility

Ages Eligible for Study:   40 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Thirty patients, between the ages of 40 and 80, of either gender, from all ethnic backgrounds will be recruited in this study.

Criteria

Inclusion Criteria:

  • Subjects who have the diagnosis of open angle glaucoma
  • Subjects who are able to speak and understand English and provide meaningful written informed consent,
  • Subjects who are willing and able to comply with all testing and requirements defined in the protocol and willing and able to comply with all required study visits.

Exclusion Criteria:

  • Subjects with previous laser treatment or intraocular surgery,
  • Subjects with history of ocular inflammation and with history of previous ocular trauma.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00986141

Locations
United States, Kentucky
University of Kentucky
Lexington, Kentucky, United States, 40506
Sponsors and Collaborators
University of Kentucky
Investigators
Study Director: Deborah Davis, Assoc V Chair Univ of KY Reseach Foundation
  More Information

No publications provided

Responsible Party: University of Kentucky
ClinicalTrials.gov Identifier: NCT00986141     History of Changes
Other Study ID Numbers: IRB 09-0315
Study First Received: September 25, 2009
Last Updated: April 23, 2013
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Glaucoma
Eye Diseases
Ocular Hypertension

ClinicalTrials.gov processed this record on November 19, 2014